Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Recursion Pharmaceuticals Inc RXRX

Healthcare Biotechnology
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RXRX)

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

GlobeNewswire 9 days ago

Recursion to Participate in Upcoming Investor Conference

GlobeNewswire April 2, 2024

Recursion Publishes Annual Environmental, Social and Governance Report

GlobeNewswire March 26, 2024

Recursion Announces Plans to Open New Office in London

GlobeNewswire March 11, 2024

Recursion Hosts Second Annual Rare Disease Day Events for Utah's Rare Disease Community

GlobeNewswire March 1, 2024

Recursion to Participate in Upcoming Investor Conferences

GlobeNewswire March 1, 2024

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire February 27, 2024

Recursion to Host Public L(earnings) Call on February 27

GlobeNewswire February 20, 2024

Altitude Lab Startups Raise Over $120M in Capital

GlobeNewswire January 24, 2024
View More News ››

Opinion & Analysis (NDAQ:RXRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RXRX)

CATHIE WOOD NOW OWNS 22 MLN SHARES.

Source: Piotr Swat / Shutterstock.com https://finance.yahoo.com/news/cathie-wood-just-bought-3-190057515.htmlRecursion...
Humanist - April 1, 2024

RXRX TO OPEN AN OFFICE IN LONDON ENGLAND & ADDED OXFORD

THEY ALSO ADDED AN OXFORD AI PROFESSOR TOTHE BOARD. AS WELL..  Recursion Announces Plans to Open New Office in London...
Humanist - March 11, 2024

Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Toda

Breaking News: $RXRX Why Recursion Pharmaceuticals Stock Dived by Nearly 17% Today2024-02-28 18:44:00 ET Recursion Pharmaceuticals...
whytestocks - February 28, 2024

Recursion Pharmaceuticals Stock Is Sliding Wednesday: What's

BREAKING NEWS: $RXRX Recursion Pharmaceuticals Stock Is Sliding Wednesday: What's Going On? | BenzingaRecursion Pharmaceuticals Inc ...
whytestocks - February 28, 2024

RE:RXRX is up 14% after hrs with good vol, i cant find any news

I have to think it's riding the NVDA tailwind after their buy in last summer
jacobite - February 26, 2024

RXRX is up 14% after hrs with good vol, i cant find any news

anyone have any idea? 
Humanist - February 14, 2024
View more Bullboard ››

Acceleware Ltd

Acceleware Ltd

Acceleware Ltd. is a Canada-based company that develops clean-tech decarbonization technologies. The Company has two business ...
View More »